Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders.
Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG, Sharma G, Dhananjaya D, Jensen G, Lee JB, Cai C, Gallant J, Bains J, Tucker JE, Facchini PJ.
Raithatha SA, et al. Among authors: bains j.
J Med Chem. 2024 Jan 25;67(2):1024-1043. doi: 10.1021/acs.jmedchem.3c01225. Epub 2023 Nov 20.
J Med Chem. 2024.
PMID: 37983270
Free PMC article.